Company research / USAQ

QHSLab, Inc. (USAQ)

CIK 0000856984 · OTC · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, QHSLab, Inc. reported revenue of $2.69M. Revenue grew 26.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $3.02M.

Key ratios (year ended 2025-12-31)

67.3%
Gross margin
4.9%
Operating margin
17.0%
Net margin
28.1%
Return on year-end equity
26.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-03

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.